Back
Chugai Pharmaceutical Vs. Nxera Pharma Industry Stock Comparison
Buy
52
CHGCY
Chugai Pharmaceutical
Last Price:
23.02
Seasonality Move:
6.78%
Buy
52
SOLTF
Nxera Pharma
Last Price:
8.05
Seasonality Move:
20.55%
Buy
52
Chugai Pharmaceutical (CHGCY)
is a Buy
Is Chugai Pharmaceutical a Buy, Sell or Hold?
- The current Chugai Pharmaceutical [CHGCY] share price is $23.55. The Score for CHGCY is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- CHGCY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
52
Nxera Pharma (SOLTF)
is a Buy
Is Nxera Pharma a Buy, Sell or Hold?
- The current Nxera Pharma [SOLTF] share price is $8.05. The Score for SOLTF is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- SOLTF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CHGCY Stock Price Chart
What is Chugai Pharmaceutical's stock price today?
-
The Chugai Pharmaceutical share price today is $23.55
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CHGCY is experiencing slight selling pressure.
SOLTF Stock Price Chart
What is Nxera Pharma's stock price today?
-
The Nxera Pharma share price today is $8.05
The current trend is relatively stagnant and SOLTF is experiencing slight buying pressure.
CHGCY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 48.67 | Sell |
| Chaikin Money Flow: | -20390 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.06 - 24.4) | Sell |
| Bollinger Bands (100): | (20.06 - 24.54) | Buy |
SOLTF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.18 | Sell |
| Relative Strength Index (14 RSI): | 52.73 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.17 - 8.57) | Buy |
| Bollinger Bands (100): | (8.14 - 10.16) | Sell |
CHGCY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.57 | Sell |
| 20-day SMA: | 23.64 | Sell |
| 50-day SMA: | 23.76 | Sell |
| 200-day SMA: | 19.93 | Buy |
| 8-day EMA: | 23.64 | Sell |
| 20-day EMA: | 23.7 | Sell |
| 50-day EMA: | 23.41 | Buy |
| 200-day EMA: | 20.53 | Buy |
SOLTF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.75 | Buy |
| 20-day SMA: | 7.58 | Buy |
| 50-day SMA: | 8.36 | Sell |
| 200-day SMA: | 9.46 | Sell |
| 8-day EMA: | 7.79 | Buy |
| 20-day EMA: | 7.83 | Buy |
| 50-day EMA: | 8.32 | Sell |
| 200-day EMA: | 9.49 | Sell |
Chugai Pharmaceutical Earnings Growth & CHGCY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nxera Pharma Earnings Growth & SOLTF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Chugai Pharmaceutical Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nxera Pharma Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||